This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX World Congress Europe
28th - 30th April 2025
Day Zero - CEO Forum Day (April 28)​Business Design Centre, London, UK
Book Now
Menu
Book Now
Key Sessions
Amanda Gett
Navigating the Future: 2025 Investment Trends Shaping the European Biotech Sector
Kurma Partners
Juergen Eckhardt
From Acquisition to Integration: Winning Strategies in Global Pharma M&A
Bayer
Alexander Zehnder
European Life Science Excellence to the World Stage: Spearheading Innovation in 2025
CureVac
Nathalie ter Wengel, M.D.
The Innovation Bridge: Mastering Biotech-Pharma Collaborations for Future Success
Pfizer
Stephen Ranjan
Why Hasn’t Digital Health Succeeded Yet and What Will it Take?
Roche
Betsabeh Madani-Hermann
The Power of Intelligence and AI to Address the Health Equity Gap
Philips
keyboard_arrow_right

Day One - GMT (Greenwich Mean Time, GMTZ)

keyboard_arrow_leftSearch & Filter
search
Day One - GMT (Greenwich Mean Time, GMTZ)
search
Showing 1 of 1 Streams
09:00 - 09:05
LSX Welcome Address: Biotech Leaders
  • Adam Griffiths - Senior Conference Director, Biotech Lead, LSX
09:05 - 09:30
Assessing Biotech Investment Trends in 2025 & Beyond
  • Cody Powers - Partner, ZS Associates
09:30 - 10:30
European Life Science Excellence to the World Stage: Spearheading Innovation in 2025
  • Alexander Zehnder - CEO, CureVac
  • Anta Gkelou - Partner, Sofinnova Partners
  • Regina Hodits - Managing Partner, Wellington Partners
  • Tim Haines - Executive Partner, Abingworth
Showing 3 of 3 Streams
11:10 - 12:00
Navigating the Future: 2025 Investment Trends Shaping the European Biotech Sector
  • Amanda Gett - Partner, Kurma Partners
  • Michael White - Head of Life Sciences, HSBC Innovation Bank, EMEA
  • Luc Dochez - Managing Partner, DROIA Ventures
  • João Incio - General Partner, Biovance Capital
  • Alex Hamilton - Partner, Syncona
12:00 - 12:50
Unlocking Early-Stage Potential: Mastering Pre-Clinical Valuation and Funding Trends in Biotech
  • Arvind Shandilya - Associate, Calculus Capital
  • Thomas Thestrup - Principal, Angelini Ventures
  • Mukul Mohanty - Senior Partner, Truffle Capital
  • Giovanni Rizzo - Partner Biotech Fund, Indaco Venture Partners
11:10 - 12:00
The Innovation Bridge: Mastering Biotech-Pharma Collaborations for Future Success
  • Nathalie ter Wengel, M.D. - European Head Worldwide Business Development, Pfizer
  • David Jenkins - SVP, Research and External Innovation, Ipsen
  • Gwilym Attwell - Principal, Fish & Richardson P.C.
  • Chris Brown - Executive Director, Business Development Transaction, GSK
  • Marcel Reichen - Exec. Director, Search and Evaluation, Novartis
  • Duncan Young - Executive Director, Oncology R&D Business Development, AstraZeneca
12:00 - 12:50
Catalyzing Life Sciences Innovation: Strengthening Collaborations Across Industry, Academia, and NPOs
  • Carina Santos - Strategic Alliance Executive, Cancer Research Horizons
  • Katie Anastasi-Frankovics - Head of Innovation and Access, The Wellcome Trust
11:10 - 11:30
Commercial Models of the Future and How the Biopharma Launch Landscape is Changing
  • Future implications for customer engagement models
  • Challenges we anticipate, and the solutions to common shortcomings with traditional commercial models
  • The evolving role of field teams, digital, omnichannel and cloud technologies and analytics
  • The path to 2030 and what companies should consider now
11:30 - 12:10
Commercial Models of The Future and How the Biopharma Launch Landscape is Changing
  • Future implications for customer engagement models
  • Challenges we anticipate, and the solutions to common shortcomings with traditional commercial models
  • The evolving role of field teams, digital, omnichannel and cloud technologies and analytics
  • The path to 2030 and what companies should consider now
12:10 - 12:50
Unlocking Biotech Success: Strategies for Driving Impactful Partnerships
  • Sandra Von Meier - Head Business Development & Licensing, Debiopharm International SA
  • Celine Cartlet - VP, Head of Transactions, Global Business Development, Galapagos
  • Helen Tayton-Martin - Chief Business Officer, Adaptimmune
  • Ragip M Ziyal - Global Head of BD&L, Tillotts Pharma
  • Ingo Lehrke - CBO, Tubulis
Showing 3 of 3 Streams
14:00 - 14:50
Fuelling Expansion: Strategic Investments for Growth Stage Biotechs
  • Mathias Vinther - Principal, Forbion
  • Felice Verduyn-van Weegen - Partner, EQT Life Sciences
  • Pierre-Louis Joffrin - Associate Partner, Syncona
14:50 - 15:40
Thriving in Turbulence: Strategies for Biotechs in the Public Market Arena
  • Edoardo Negroni - Co-Founder & Managing Partner, AurorA-TT
  • Edward van Wezel - Managing Partner, Biogeneration Ventures
  • Herve de Kergrohen - Venture Partner, Alpha Blue Ocean
  • Edouard Guillet - MD, IPF Partners
14:00 - 14:50
Unlocking Potential: Strategic Approaches to Licensing in Pharma and Biotech
  • Christopher Church - Head of Technology Search, Evaluation and Transactions, AstraZeneca
  • Bernd Muehlenweg - SVP, Global BD, Evotec
  • Anja Bitterwolf - Business Development & Licensing Manager, Debiopharm International SA
14:50 - 15:40
CNS + Neurology Success: Strategies for Enhanced Collaboration in Biotech and Pharma Partnerships
  • Keld Flintholm Jørgensen - SVP and Chief Business Officer, Lundbeck
  • Olga Krylova - Head of S&E, Europe, Global Business Development & Innovation, Otsuka
  • Rowan Gardner - CBIO, Precision Life
14:00 - 14:50
Early Commercialization Planning for Biotech
  • Colleen Acosta - CEO-Founder & CEO, Freya Biosciences
  • Sana Alajmovic - Co-Founder & CEO, Sigrid Therapeutics
  • Martijn Negen - COO, VarmX
  • Jenny Barnett - CEO, Monument Therapeutics
14:50 - 15:40
Bridging the Gap: Overcoming Challenges from Research to Commercialization in Biotech
  • Melissa Faris - CBO, OMass Therapeutics
  • Maria Dahl - COO and Head of Innovent Biologics (Europe), Innovent Biologics
  • Audrey Dufour - Director, Corporate Business Development, Lundbeck
Showing 1 of 1 Streams
16:20 - 17:00
Cultivating Success: Building a Vibrant Transatlantic Biotech Culture
  • Susan Hill - CEO, Mestag Therapeutics
  • Antony Mattessich - CEO, Amphista
  • Renee Aguiar-Lucander - Chief Executive Officer, Calliditas Therapeutics
17:00 - 17:40
From Acquisition to Integration: Winning Strategies in Global Pharma M&A
  • Juergen Eckhardt - EVP, Head of Leaps by Bayer, Head of Pharma BD&L, Bayer
  • Matthias Müllenbeck - SVP, Head Global BD & Alliance Management, Merck KGaA
  • Michelle Li - Vice President and Head, BD&L Transactions, Bristol Myers Squibb
Day Zero - CEO Forum Day
NextPharma Leaders Forums
Filter
Streams
Clear
Formats
Choose Day